BRCA1 mutated breast cancers are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) and are classified as TNBC [128]. This evidence concerns the gene ERBB2 and breast carcinoma.